Previous 10 | Next 10 |
home / stock / orxoy / orxoy news
Orexo Q3 2023 Interim Report PR Newswire Big step forward in launching OX124 in the US UPPSALA, Sweden , Nov. 2, 2023 /PRNewswire/ -- Q3 2023 highlights › Total net revenues of SEK 156.1 m (161.0) › ...
Orexo announces changes in the company´s Board of Directors PR Newswire UPPSALA, Sweden , Oct. 27, 2023 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), announces that Robin Evers , Senior Vice President, Head of Global Regulatory Affairs &am...
Orexo´s Nomination Committee for the Annual General Meeting 2024 PR Newswire UPPSALA, Sweden , Oct. 26, 2023 /PRNewswire/ -- Prior to the Annual General Meeting (AGM) in 2024, that will take place on April 26 , a Nomination Committee has been appointed. ...
Report from Orexo´s extraordinary general meeting PR Newswire STOCKHOLM , Oct. 26, 2023 /PRNewswire/ -- Election of new member of the board of directors The extraordinary general meeting in Orexo AB (publ) on 26 October 2023 resolved, in accordan...
Orexo announces data from the MODIA® study evaluating impact on use of illicit opioids PR Newswire The six-month randomized controlled trial (RCT) enrolled 437 participants at 36 sites across the US The study demonstrated no statistically significant difference betwee...
Notice of Extraordinary General Meeting in Orexo AB (publ) PR Newswire UPPSALA, Sweden , Oct. 3, 2023 /PRNewswire/ -- Orexo AB (publ), Reg. No. 556500-0600, with its registered office in Uppsala, gives notice of the Extraordinary General Meeting to be held on ...
Orexo to participate in Pareto Securities´ 14th Annual Healthcare Conference 2023 PR Newswire UPPSALA, Sweden , Sept. 5, 2023 /PRNewswire/ -- Orexo AB (Publ.), (STO:ORX) (OTCQX:ORXOY) , today announces the company will participate in Pareto Securit...
Orexo secures patent protection in the US for OX640, a nasal epinephrine powder product PR Newswire UPPSALA, Sweden , Aug. 29, 2023 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that the United States Patent and Trademark Office...
Orexo's patent win for ZUBSOLV® appealed PR Newswire UPPSALA, Sweden , July 24, 2023 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global, Inc.,...
2023-07-18 03:01:56 ET Orexo AB press release ( OTCQX:ORXOY ): Q2 GAAP EPS of -SEK 0.37. Revenue of SEK 157.7 million (+6.7% Y/Y). Positive EBITDA of SEK 5.6 million in Q2 (SEK -32.5 million Q2, 2022, and SEK -41.1 million Q1, 2023). Cash flow from operating ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum held June 20 th are now available for online viewing. REGISTER NOW AT : ...
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Virtual Investor Forum to be held on June 20 th , 2024. This event is co-sponsored by Zack’s Small Cap Research. ...
Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm PR Newswire UPPSALA, Sweden , May 10, 2024 /PRNewswire/ -- On March 28, 2024 , Orexo AB (publ), ("Orexo" or the " Company ") (STO: ORX) (OTCQX: ORXOY) succ...